Dr. Drew C. Murray
Medical Oncology (Medical Oncology Physician)
3301 Squalicum Pkwy
Bellingham, WA 98225
Who else practices at this address →
Whatcom County is a federal primary care and dental and mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 11
- In the NPI registry since
- 2015
- Medicare patients seen, 2024
- 307
Licensed in Washington since 2020, according to the Washington State Department of Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
WA license MD61092211 (first issued 2020; active) -
Hematology (Internal Medicine) Physician
WA license MD61092211 (first issued 2020; active) -
Hematology & Oncology Physician
KY license 51539 -
Internal Medicine Physician
WA license MD61092211 (first issued 2020; active) - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Peacehealth St Joseph Medical Center Bellingham, WA
- Dominican Hospital Santa Cruz, CA
- Peacehealth United General Medical Center Sedro Woolley, WA
- Peacehealth Peace Island Medical Center Friday Harbor, WA
Medical groups
- Dignity Health Medical Foundation (1,184 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 307
- Services billed
- 1,642
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 479 | 186 |
| Established patient office or other outpatient visit, 40-54 minutes | 206 | 77 |
| New patient office or other outpatient visit, 60-74 minutes | 60 | 60 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 19 | 18 |
| Established patient office or other outpatient visit, 20-29 minutes | 13 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Dexamethasone Other prescribers in Bellingham, WA | 147 |
| Prednisone Other prescribers in Bellingham, WA | 130 |
| Prochlorperazine Maleate Other prescribers in Bellingham, WA | 102 |
| Letrozole Other prescribers in Bellingham, WA | 92 |
| Acyclovir Other prescribers in Bellingham, WA | 85 |
| Ondansetron Hcl Other prescribers in Bellingham, WA | 85 |
| Abiraterone Acetate | 82 |
| Potassium Chloride Other prescribers in Bellingham, WA | 75 |
| Eliquis (apixaban) Other prescribers in Bellingham, WA | 74 |
| Hydroxyurea Other prescribers in Bellingham, WA | 71 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 7 payments worth $165 in total to this clinician.
| Janssen Biotech, Inc. | $58.36 |
|---|---|
| Novartis Pharmaceuticals Corporation | $43.35 |
| Tempus Ai, Inc | $24.72 |
| Acrotech Biopharma Inc. | $22.10 |
| E.r. Squibb & Sons, L.l.c. | $16.44 |
| Food and Beverage | $165 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $81,332 in research payments for these studies, mostly to the institutions running them.
- Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation
Mirati Therapeutics, Inc. · Active, not recruiting · NCT05609578
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.